These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 1489195)

  • 21. Ciprofloxacin during upper respiratory tract infections to reduce Pseudomonas aeruginosa infection in paediatric cystic fibrosis: a pilot study.
    Connett GJ; Pike KC; Legg JP; Cathie K; Dewar A; Foote K; Harris A; Faust SN
    Ther Adv Respir Dis; 2015 Dec; 9(6):272-80. PubMed ID: 26341118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regular three monthly oral ciprofloxacin in adult cystic fibrosis patients infected with Pseudomonas aeruginosa.
    Sheldon CD; Assoufi BK; Hodson ME
    Respir Med; 1993 Nov; 87(8):587-93. PubMed ID: 8290742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials.
    Haworth CS; Bilton D; Chalmers JD; Davis AM; Froehlich J; Gonda I; Thompson B; Wanner A; O'Donnell AE
    Lancet Respir Med; 2019 Mar; 7(3):213-226. PubMed ID: 30658914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous versus oral antibiotics for eradication of Pseudomonas aeruginosa in cystic fibrosis (TORPEDO-CF): a randomised controlled trial.
    Hewer SCL; Smyth AR; Brown M; Jones AP; Hickey H; Kenna D; Ashby D; Thompson A; Williamson PR;
    Lancet Respir Med; 2020 Oct; 8(10):975-986. PubMed ID: 33007285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utilization of salivary concentrations of ciprofloxacin in subjects with cystic fibrosis.
    Smith A; Weber A; Pandher R; Williams-Warren J; Cohen ML; Ramsey B
    Infection; 1997; 25(2):106-8. PubMed ID: 9108186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative pharmacokinetics of ciprofloxacin and ofloxacin in cystic fibrosis patients.
    Pedersen SS; Jensen T; Hvidberg EF
    J Antimicrob Chemother; 1987 Oct; 20(4):575-83. PubMed ID: 3479419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered disposition of fleroxacin in patients with cystic fibrosis.
    Mimeault J; Vallée F; Seelmann R; Sörgel F; Ruel M; LeBel M
    Clin Pharmacol Ther; 1990 May; 47(5):618-28. PubMed ID: 2111750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
    Bhatt J; Jahnke N; Smyth AR
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD002009. PubMed ID: 31483853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Individual pharmacokinetic variation leads to underdosing of ciprofloxacin in some cystic fibrosis patients.
    Schultz AN; Høiby N; Nielsen XC; Pressler T; Dalhoff K; Duno M; Buchard A; Johansen HK; Wang H; Dalbøge CS
    Pediatr Pulmonol; 2017 Mar; 52(3):319-323. PubMed ID: 28221736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Population pharmacokinetics of ciprofloxacin in pediatric patients.
    Rajagopalan P; Gastonguay MR
    J Clin Pharmacol; 2003 Jul; 43(7):698-710. PubMed ID: 12856383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral ciprofloxacin vs. intravenous ceftazidime plus tobramycin in pediatric cystic fibrosis patients: comparison of antipseudomonas efficacy and assessment of safety with ultrasonography and magnetic resonance imaging. Cystic Fibrosis Study Group.
    Richard DA; Nousia-Arvanitakis S; Sollich V; Hampel BJ; Sommerauer B; Schaad UB
    Pediatr Infect Dis J; 1997 Jun; 16(6):572-8. PubMed ID: 9194107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ciprofloxacin Dry Powder for Inhalation in Patients with Non-Cystic Fibrosis Bronchiectasis or Chronic Obstructive Pulmonary Disease, and in Healthy Volunteers.
    Stass H; Nagelschmitz J; Kappeler D; Sommerer K; Kietzig C; Weimann B
    J Aerosol Med Pulm Drug Deliv; 2017 Feb; 30(1):53-63. PubMed ID: 27448179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of serious infections with intravenous ciprofloxacin.
    Scully BE; Neu HC
    Am J Med; 1987 Apr; 82(4A):369-75. PubMed ID: 3555062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of ciprofloxacin in cystic fibrosis patients.
    Bosso JA
    Am J Med; 1989 Nov; 87(5A):123S-127S. PubMed ID: 2589355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic profiles of ciprofloxacin after single intravenous and oral doses.
    Lettieri JT; Rogge MC; Kaiser L; Echols RM; Heller AH
    Antimicrob Agents Chemother; 1992 May; 36(5):993-6. PubMed ID: 1510426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis.
    Bilton D; Henig N; Morrissey B; Gotfried M
    Chest; 2006 Nov; 130(5):1503-10. PubMed ID: 17099030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of unique ciprofloxacin pharmacokinetic characteristics in patients with cystic fibrosis.
    Reed MD; Stern RC; Myers CM; Yamashita TS; Blumer JL
    J Clin Pharmacol; 1988 Aug; 28(8):691-9. PubMed ID: 3216035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ciprofloxacin: comparative data in cystic fibrosis.
    Rubio TT
    Am J Med; 1987 Apr; 82(4A):185-8. PubMed ID: 3555034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and pharmacodynamics of ciprofloxacin in cystic fibrosis patients.
    LeBel M; Bergeron MG; Vallée F; Fiset C; Chassé G; Bigonesse P; Rivard G
    Antimicrob Agents Chemother; 1986 Aug; 30(2):260-6. PubMed ID: 3094438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
    Hansen CR; Pressler T; Høiby N
    J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.